ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding ESSA Pharma Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 36 | 31 | −5 |
| Shares | 33.5M | 34.8M | +1.30M (+3.9%) |
| Value | $103.4M | $229.4M | +$126.0M (+121.9%) |
New holders (4)
Institutions that held ESSA Pharma Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RTW Investments, LP | 2,298,662 | $15.2M | 0.24% |
| Janus Henderson Group PLC | 1,089,482 | $7.13M | 0.00% |
| Renaissance Technologies LLC | 24,234 | $160.0K | 0.00% |
| American Century Companies Inc | 20,044 | $132.3K | 0.00% |
Sold out (9)
Institutions that held ESSA Pharma Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| OrbiMed Advisors LLC | 842,366 | $2.60M |
| Millennium Management LLC | 473,556 | $1.46M |
| Susquehanna International Group, LLP | 95,758 | $295.9K |
| Connective Capital Management, LLC | 84,578 | $261.3K |
| Two Sigma Advisers, LP | 56,900 | $175.8K |
| Acadian Asset Management LLC | 15,903 | $48.0K |
| Two Sigma Investments, LP | 15,188 | $46.9K |
| Hunting Hill Global Capital, LLC | 10,000 | $30.9K |
| Newbridge Financial Services Group, Inc. | 31 | $96 |